✦ LIBER ✦

Effect of infliximab on sight-threatening panuveitis in Behcet's disease

✍ Scribed by PP Sfikakis; PG Theodossiadis; CG Katsiari; P Kaklamanis; NN Markomichelakis

Book ID: 117277886
Publisher: The Lancet
Year: 2001
Tongue: English
Weight: 734 KB
Volume: 358
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(01)05497-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of infliximab on threatening panu

Effect of infliximab on threatening panuveitis in Behçet's disease

✍ Santiago Muñoz-Fernández; Ventura Hidalgo; Julia Fernández-Melón; Armelle Schlin 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 46 KB

Infliximab beneficial in Behçet's diseas

Infliximab beneficial in Behçet's disease-associated panuveitis

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Successful treatment of life-threatening

Successful treatment of life-threatening intestinal ulcer in Behçet’s disease with infliximab: rapid healing of Behçet’s ulcer with infliximab

✍ Ji Hyeon Ju; Seung-Ki Kwok; Soo-Hong Seo; Chong-Hyeon Yoon; Ho-Youn Kim; Sung-Hw 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 111 KB

Successful treatment of cervical esophag

Successful treatment of cervical esophageal perforation in behcet’s disease with drainage operation and infliximab

✍ Thomas Mussack; Nikola Landauer; Roland Ladurner; Uwe Schiemann; Manuela Goetzbe 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 53 KB

W1140 Effect of Infliximab On Strictures

W1140 Effect of Infliximab On Strictures in Crohn's Disease

✍ Bhat, Shivaram; Sharma, Divyesh; Caddy, Grant R.; Tham, Tony 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Cyclosporine effects on optic nerve and

Cyclosporine effects on optic nerve and retinal vasculitis in Behcet's disease

✍ Pamela S. Chavis; Sobhi R. Antonios; Khalid F. Tabbara 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 809 KB

In a prospective, open clinical trial, we studied long-term effects of cyclosporine (CsA) on the optic nerve and retinal vasculitis in 14 Behçet's disease patients. Patients were treated with CsA and corticosteroids for a mean period of 42 months, with a range of 36 to 52 months. They received an in